Development of symptomatic brain metastases after chemoradiotherapy for stage III non-small cell lung cancer: Does the type of chemotherapy regimen matter?

Lizza E. L. Hendriks*, Anita J. W. M. Brouns, Mohammad Amini, Wilma Uyterlinde, Robin Wijsman, Jan Bussink, Bonne Biesma, S. Bing Oei, Jos A. Stigt, Gerben P. Bootsma, Jose S. A. Belderbos, Dirk K. M. De Ruysscher, Michel M. Van den Heuvel, Anne-Marie C. Dingemans

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Development of symptomatic brain metastases after chemoradiotherapy for stage III non-small cell lung cancer: Does the type of chemotherapy regimen matter?'. Together they form a unique fingerprint.

Keyphrases

INIS

Pharmacology, Toxicology and Pharmaceutical Science

Nursing and Health Professions

Agricultural and Biological Sciences

Immunology and Microbiology